Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gazzard

Showing results (31-40 of 373) with videos related to

Pageof 38
Sort By:
The American Journal of Medicine|March 1, 1995
Foscarnet or ganciclovir for treatment of AIDS and CMV retinitisG Moyle, B G Gazzard
Annals of Clinical Biochemistry|May 1, 1984
Have chemical tests a role in diagnosing malabsorption?A Theodossi, B G Gazzard
Journal of HIV Therapy|May 8, 2003
Clinical utility of resistance testingJustin Stebbing, Brian G Gazzard
British Journal of Clinical Practice. Supplement|September 1, 1990
Oral candidosis in HIV-infected patientsB G Gazzard, D Smith
Journal of HIV Therapy|July 9, 2004
Does atazanavir cause lipodystrophy?Brian G Gazzard, Graeme Moyle
Gut|November 1, 1984
Weight loss caused by a thalamic astrocytomaJ M Goldman, B G Gazzard
Journal of the Royal Society of Medicine|May 1, 1983
Hairy cell leukaemia presenting as aplastic anaemiaJ J Dixey, B G Gazzard
BMJ (Clinical Research Ed.)|February 12, 2005
Rising rates of HIV infectionAngela J Robinson, Brian G Gazzard
Drug Safety|May 7, 1999
A risk-benefit assessment of HIV protease inhibitorsG J Moyle, B G Gazzard
Antiviral Therapy|July 1, 1997
The role of didanosine in the management of HIV-1 infectionB G Gazzard, G J Moyle
Pageof 38

Showing results (31-40 of 373) with videos related to

Sort By:
Pageof 38
The American Journal of Medicine|March 1, 1995
Foscarnet or ganciclovir for treatment of AIDS and CMV retinitisG Moyle, B G Gazzard
Annals of Clinical Biochemistry|May 1, 1984
Have chemical tests a role in diagnosing malabsorption?A Theodossi, B G Gazzard
Journal of HIV Therapy|May 8, 2003
Clinical utility of resistance testingJustin Stebbing, Brian G Gazzard
British Journal of Clinical Practice. Supplement|September 1, 1990
Oral candidosis in HIV-infected patientsB G Gazzard, D Smith
Journal of HIV Therapy|July 9, 2004
Does atazanavir cause lipodystrophy?Brian G Gazzard, Graeme Moyle
Gut|November 1, 1984
Weight loss caused by a thalamic astrocytomaJ M Goldman, B G Gazzard
Journal of the Royal Society of Medicine|May 1, 1983
Hairy cell leukaemia presenting as aplastic anaemiaJ J Dixey, B G Gazzard
BMJ (Clinical Research Ed.)|February 12, 2005
Rising rates of HIV infectionAngela J Robinson, Brian G Gazzard
Drug Safety|May 7, 1999
A risk-benefit assessment of HIV protease inhibitorsG J Moyle, B G Gazzard
Antiviral Therapy|July 1, 1997
The role of didanosine in the management of HIV-1 infectionB G Gazzard, G J Moyle
Pageof 38